Put Options

31 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $16.2 Million - $18.6 Million
625,000 Added 41.17%
2,143,200 $59.5 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $18.4 Million - $23.9 Million
703,100 Added 86.26%
1,518,200 $43.7 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $8.52 Million - $9.96 Million
-265,400 Reduced 24.56%
815,100 $27 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $2.14 Million - $2.48 Million
-59,300 Reduced 5.2%
1,080,500 $39.6 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $23.2 Million - $30.2 Million
589,700 Added 107.2%
1,139,800 $46.5 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $5.64 Million - $7.37 Million
-135,200 Reduced 19.73%
550,100 $28.2 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $21.8 Million - $26.6 Million
-497,900 Reduced 42.08%
685,300 $30 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $9.15 Million - $10.8 Million
-196,600 Reduced 14.25%
1,183,200 $62 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $63.1 Million - $78.2 Million
1,379,800 New
1,379,800 $71.4 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $142 Million - $210 Million
-3,429,200 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $41.8 Million - $62 Million
-1,012,400 Reduced 22.79%
3,429,200 $202 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $174 Million - $224 Million
4,441,600 New
4,441,600 $191 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $79.7 Million - $102 Million
-2,030,600 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $72.9 Million - $82.6 Million
2,030,600 New
2,030,600 $79.5 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $65 Million - $73.3 Million
-1,939,400 Reduced 52.59%
1,748,300 $63.3 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $58.6 Million - $66 Million
-1,748,300 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $123 Million - $157 Million
3,687,700 New
3,687,700 $136 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $162 Million - $206 Million
-4,849,100 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $32.4 Million - $38 Million
1,021,000 Added 26.67%
4,849,100 $178 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $26.6 Million - $32.2 Million
881,800 Added 29.93%
3,828,100 $125 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $42.1 Million - $60.1 Million
1,555,700 Added 111.87%
2,946,300 $96.2 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $11.4 Million - $13 Million
-346,700 Reduced 19.96%
1,390,600 $54.5 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $47.4 Million - $61.4 Million
-1,457,700 Reduced 45.62%
1,737,300 $59.2 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $42.1 Million - $47.2 Million
1,137,500 Added 55.29%
3,195,000 $138 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $53.4 Million - $58.7 Million
1,423,600 Added 224.58%
2,057,500 $87.4 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $17.7 Million - $20.2 Million
459,700 Added 263.89%
633,900 $27.7 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $33.5 Million - $40.6 Million
-970,600 Reduced 84.78%
174,200 $7.68 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $28.1 Million - $30 Million
-852,000 Reduced 42.67%
1,144,800 $41.5 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $47.8 Million - $55.4 Million
1,496,800 Added 299.36%
1,996,800 $70.9 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $4.96 Million - $5.27 Million
149,200 Added 42.53%
500,000 $18.1 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $10.9 Million - $12 Million
350,800
350,800 $12.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.